Extracellular Matrix Protein-1 as a Mediator of Inflammation-Induced Fibrosis After Myocardial Infarction

Area of Science:

• Cardiovascular Biology
• Fibrosis Research
• Molecular Mechanisms of Heart Disease

Background:

• Irreversible fibrosis is a key characteristic of myocardial infarction (MI) and heart failure.
• Extracellular matrix protein-1 (ECM-1) is found at elevated levels in fibrotic and inflammatory regions of injured hearts.

Purpose of the Study:

• To investigate the role of Extracellular matrix protein-1 (ECM-1) in cardiac fibrosis.
• To identify the cellular sources and signaling pathways of ECM-1 in the context of myocardial infarction.

Main Methods:

• Immunohistochemistry to localize ECM-1 in cardiac tissue.
• Cell culture experiments to assess ECM-1's effects on cardiac fibroblasts.
• Inhibition studies using LRP1 antagonists.

Main Results:

• ECM-1 is produced by fibroblasts, macrophages, and vascular cells, with increased M1/M2 macrophage and myofibroblast involvement post-MI.
• ECM-1 promotes fibroblast-to-myofibroblast transition and upregulates fibrotic and inflammatory pathways.
• ECM-1 inhibits cardiac fibroblast migration.
• ECM-1 binds to the LRP1 receptor on cardiac fibroblasts, mediating its pro-fibrotic effects.

Conclusions:

• A novel ECM-1-LRP1 signaling axis promotes cardiac fibrosis after myocardial infarction.
• ECM-1 represents a potential therapeutic target for mitigating inflammation-fibrosis crosstalk in heart disease.